Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Big Yellow Group PLC
LSE:BYG
|
UK |
|
Kawasaki Heavy Industries Ltd
OTC:KWHIY
|
JP |
|
China Nonferrous Gold Ltd
LSE:CNG
|
KY |
|
ACM Research Shanghai Inc
SSE:688082
|
CN |
|
W
|
Winox Holdings Ltd
HKEX:6838
|
HK |
|
V
|
Volato Group Inc
AMEX:SOAR
|
US |
|
Sunkwan Properties Group Ltd
HKEX:6900
|
CN |
|
B
|
Bombay Super Hybrid Seeds Ltd
NSE:BSHSL
|
IN |
|
Hellenic Telecommunications Organization SA
OTC:HLTOF
|
GR |
|
Competent Automobiles Company Ltd
BSE:531041
|
IN |
During the last 3 months Rigel Pharmaceuticals Inc insiders have not bought any shares, and sold 145.4k USD worth of shares. The stock price has dropped by 11% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/rigl/vs/indx/gspc">open performance analysis).
The last transaction was made on
Feb 20, 2026
by
Moos Walter H
, who
sold
145.4k USD
worth of
RIGL shares.
During the last 3 months Rigel Pharmaceuticals Inc insiders have not bought any shares, and sold 145.4k USD worth of shares. The stock price has dropped by 11% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/rigl/vs/indx/gspc">open performance analysis).
The last transaction was made on
Feb 20, 2026
by
Moos Walter H
, who
sold
145.4k USD
worth of
RIGL shares.
Rigel Pharmaceuticals Inc
Glance View
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company is headquartered in South San Francisco, California and currently employs 165 full-time employees. The company went IPO on 2000-11-29. The firm is engaged in discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. The firm's research focuses on signaling pathways that are critical to disease mechanisms. The firm's product, TAVALISSE (fostamatinib disodium hexahydrate) tablets, the spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia (ITP). The Company’s product is also commercially available in Europe, the United Kingdom (UK) (TAVLESSE) and Canada (TAVALISSE) for the treatment of chronic ITP in adult patients. Its clinical programs include its interleukin receptor-associated kinase (IRAK) inhibitor program and a receptor-interacting serine/threonine-protein kinase (RIPK1) inhibitor program in clinical development with partner Eli Lilly and Company (Lilly).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.